Cue Biopharma, Inc. Quarterly Return On Equity in % from Q3 2018 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cue Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q2 2024.
  • Cue Biopharma, Inc. Return On Equity for the quarter ending June 30, 2024 was -143 %, a 49.9% decline year-over-year.
  • Cue Biopharma, Inc. annual Return On Equity for 2023 was -112 %, a 27.5% decline from 2022.
  • Cue Biopharma, Inc. annual Return On Equity for 2022 was -88 %, a 35.3% decline from 2021.
  • Cue Biopharma, Inc. annual Return On Equity for 2021 was -65 %, a 5.96% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -143 -47.6 -49.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -128 -38.6 -43% Jan 1, 2024 Mar 31, 2024
Q4 2023 -112 -24.2 -27.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -99.1 -21.4 -27.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -95.4 -18.3 -23.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -89.7 -20.8 -30.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -88 -23 -35.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -77.8 -12 -18.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -77.1 -20.2 -35.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -68.9 -12.6 -22.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -65 -3.66 -5.96% Oct 1, 2021 Dec 31, 2021
Q3 2021 -65.8 -2.1 -3.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 -56.8 +19.6 +25.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -56.2 +47.8 +45.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -61.4 +54.6 +47.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -63.7 +84.9 +57.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -76.5 +75.4 +49.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -104 +12 +10.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 -116 -28.3 -32.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -149 -75 -102% Jul 1, 2019 Sep 30, 2019
Q2 2019 -152 Apr 1, 2019 Jun 30, 2019
Q1 2019 -116 Jan 1, 2019 Mar 31, 2019
Q4 2018 -87.7 Oct 1, 2018 Dec 31, 2018
Q3 2018 -73.6 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.